Medication info
Rosuvastatin Calcium 10 mg Tablets

Rosuvastatin Calcium 10 mg Tablets

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
NBK Pharmaceutical Co., Ltd.
Appearance
Pink, round film-coated tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 201906578 · Approved 2019.09.19 · Insurance code 054800380

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately according to LDL cholesterol levels, treatment goals, and patient response at intervals of 4 weeks or longer, and may be increased up to a maximum of 20 milligrams per day. 3. Older adults : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Safety and efficacy in children under 10 years of age have not been established.

Ingredients

Manufacturer
NBK Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease

  • Primary hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol
  • smoking
  • family history of early coronary heart disease
  • risk of stroke
View approved original text

This medication is primarily used as an adjunct when diet and exercise alone are insufficient for controlling primary hypercholesterolemia and mixed dyslipidemia. It also helps patients with homozygous familial hypercholesterolemia or children aged 10 to 17 years with heterozygous familial hypercholesterolemia, in combination with dietary therapy. This medication lowers total cholesterol and LDL cholesterol levels, slows the progression of atherosclerosis, and is also used for patients with primary dysbetalipoproteinemia. Additionally, it helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in middle-aged patients with a high risk of cardiovascular disease. Therefore, this medication is used to improve hypercholesterolemia and associated cardiovascular disease risks.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately according to LDL cholesterol levels, treatment goals, and patient response at intervals of 4 weeks or longer, and may be increased up to a maximum of 20 milligrams per day. 3. Older adults : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Safety and efficacy in children under 10 years of age have not been established.

Precautions

This medication should not be used in certain patients. For example, patients with an allergy to this medication's components, with active liver disease, with muscle disorders, those with severe impairment of certain kidney functions, women who are pregnant or breastfeeding, and fertile women not using adequate contraception should not take this medication. Furthermore, this medication should be used with caution in patients at high risk of muscle injury. Elderly patients, those with hypothyroidism, patients with mild impairment of kidney function, alcohol abusers, and those with a history of certain genetic muscle disorders should consult with a physician before taking this medication. During treatment with this medication, regular liver function tests should be done, and any symptoms such as muscle pain, muscle weakness, or muscle cramps should be reported to healthcare professionals immediately. Additionally, severe muscle injury or rhabdomyolysis can occur, and if symptoms are severe, the medication should be discontinued. This medication may interact with other drugs, so it is crucial to inform healthcare professionals about any other medications being taken. In particular, the risk of muscle injury may increase when used in combination with certain antibiotics, antifungals, immunosuppressants, and fibrate medications. Pregnant or breastfeeding women should not use this medication, and fertile women should use proper contraception before taking this medication. In cases of overdose, there is no specific antidote, so one should visit a medical institution immediately for proper treatment, and liver function and muscle enzyme levels should be monitored regularly. Lastly, this medication may cause dizziness when driving or operating machinery, so caution is advised. Finally, this medication contains lactose and should not be administered to patients with lactose intolerance or related genetic disorders.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular muscle weakness, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruptions, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increase in ALT, chest pain, muscle cramps, gout, erectile dysfunction, increase in AST, numbness, sensory disturbances, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly closed container to prevent air or moisture from entering, and it is best stored at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Pink, round film-coated tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.